» Articles » PMID: 30894629

A Reference Collection of Patient-derived Cell Line and Xenograft Models of Proneural, Classical and Mesenchymal Glioblastoma

Abstract

Low-passage, serum-free cell lines cultured from patient tumour tissue are the gold-standard for preclinical studies and cellular investigations of glioblastoma (GBM) biology, yet entrenched, poorly-representative cell line models are still widely used, compromising the significance of much GBM research. We submit that greater adoption of these critical resources will be promoted by the provision of a suitably-sized, meaningfully-described reference collection along with appropriate tools for working with them. Consequently, we present a curated panel of 12 readily-usable, genetically-diverse, tumourigenic, patient-derived, low-passage, serum-free cell lines representing the spectrum of molecular subtypes of IDH-wildtype GBM along with their detailed phenotypic characterisation plus a bespoke set of lentiviral plasmids for bioluminescent/fluorescent labelling, gene expression and CRISPR/Cas9-mediated gene inactivation. The cell lines and all accompanying data are readily-accessible via a single website, Q-Cell (qimrberghofer.edu.au/q-cell/) and all plasmids are available from Addgene. These resources should prove valuable to investigators seeking readily-usable, well-characterised, clinically-relevant, gold-standard models of GBM.

Citing Articles

PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer.

Ran X, Wu B, Vidhyasagar V, Song L, Zhang X, Ladak R Nat Commun. 2025; 16(1):2166.

PMID: 40038278 PMC: 11880360. DOI: 10.1038/s41467-025-57257-z.


In Vitro Evaluation of Genetically Unmodified Ligand-Armed Allogeneic Natural Killer Cells to Treat EGFR-Positive Glioblastoma.

Courot H, Rigal E, Adib N, Criton M, Cookson A, Fauvel B Cells. 2025; 14(4).

PMID: 39996727 PMC: 11854314. DOI: 10.3390/cells14040254.


STING-induced noncanonical autophagy regulates endolysosomal homeostasis.

Huang T, Sun C, Du F, Chen Z Proc Natl Acad Sci U S A. 2025; 122(8):e2415422122.

PMID: 39982740 PMC: 11874320. DOI: 10.1073/pnas.2415422122.


Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine.

Mann B, Artz N, Darawsheh R, Kram D, Hingtgen S, Satterlee A NPJ Precis Oncol. 2025; 9(1):47.

PMID: 39953052 PMC: 11828933. DOI: 10.1038/s41698-025-00832-w.


Multidimensional, integrative profiling identifies BCL2L1 methylation as a predictor of MCL1 dependency in pediatric malignancies.

Adjumain S, Daniel P, Sun C, Bradshaw G, Chew N, Tsui V JCI Insight. 2025; 10(2).

PMID: 39846250 PMC: 11790018. DOI: 10.1172/jci.insight.184601.


References
1.
Chen J, Li Y, Yu T, McKay R, Burns D, Kernie S . A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012; 488(7412):522-6. PMC: 3427400. DOI: 10.1038/nature11287. View

2.
Mikeska T, Felsberg J, Hewitt C, Dobrovic A . Analysing DNA methylation using bisulphite pyrosequencing. Methods Mol Biol. 2011; 791:33-53. DOI: 10.1007/978-1-61779-316-5_4. View

3.
Abuhusain H, Matin A, Qiao Q, Shen H, Kain N, Day B . A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis. J Biol Chem. 2013; 288(52):37355-64. PMC: 3873587. DOI: 10.1074/jbc.M113.494740. View

4.
Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View

5.
Patel A, Tirosh I, Trombetta J, Shalek A, Gillespie S, Wakimoto H . Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014; 344(6190):1396-401. PMC: 4123637. DOI: 10.1126/science.1254257. View